Why the FDA’s push for real-time clinical trials could favor Big Pharma

Why the FDA’s push for real-time clinical trials could favor Big Pharma is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Alivia Kaylor · 2026-05-13

The agency's new initiative promises faster drug approval times, but smaller trial sponsors could struggle to keep up.

Source: PharmaVoice